Selected research
Market Outlook & Growth Opportunities
Global Standard Peptide Custom Synthesis Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Standard Peptide Custom Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Standard Peptide Custom Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Standard Peptide Custom Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Standard Peptide Custom Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Standard Peptide Custom Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Standard Peptide Custom Synthesis Service market include Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm and Genscript, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Standard Peptide Custom Synthesis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Standard Peptide Custom Synthesis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Standard Peptide Custom Synthesis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Standard Peptide Custom Synthesis Service market.
Standard Peptide Custom Synthesis Service Segment by Company
Bachem
PolyPeptide
GL Biochem
Xinbang
Hybio
USVPeptides
Thermofischer
ScinoPharm
Genscript
AnaSpec
New England Peptide
CPC Scientific
JPT
21st Century Bio
LifeTein
Proimmune
Biomatik
Standard Peptide Custom Synthesis Service Segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Standard Peptide Custom Synthesis Service Segment by Application
Commercial
Academic Research
Standard Peptide Custom Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Standard Peptide Custom Synthesis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Standard Peptide Custom Synthesis Service key companies, revenue, market share, and recent developments.
3. To split the Standard Peptide Custom Synthesis Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Standard Peptide Custom Synthesis Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Standard Peptide Custom Synthesis Service significant trends, drivers, influence factors in global and regions.
6. To analyze Standard Peptide Custom Synthesis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Standard Peptide Custom Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Standard Peptide Custom Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Standard Peptide Custom Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Standard Peptide Custom Synthesis Service industry.
Chapter 3: Detailed analysis of Standard Peptide Custom Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Standard Peptide Custom Synthesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Standard Peptide Custom Synthesis Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Standard Peptide Custom Synthesis Service Industry Trends
Table 2. Standard Peptide Custom Synthesis Service Industry Drivers
Table 3. Standard Peptide Custom Synthesis Service Industry Opportunities and Challenges
Table 4. Standard Peptide Custom Synthesis Service Industry Restraints
Table 5. Global Standard Peptide Custom Synthesis Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Standard Peptide Custom Synthesis Service Revenue Share by Company (2021-2026)
Table 7. Global Standard Peptide Custom Synthesis Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Standard Peptide Custom Synthesis Service Key Company Manufacturing Base & Headquarters
Table 9. Global Standard Peptide Custom Synthesis Service Company, Product Type & Application
Table 10. Global Standard Peptide Custom Synthesis Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Standard Peptide Custom Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of CRO Peptides
Table 15. Significant Companies of CMO Peptides
Table 16. Significant Companies of Generic API Peptides
Table 17. Global Standard Peptide Custom Synthesis Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Standard Peptide Custom Synthesis Service Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Standard Peptide Custom Synthesis Service Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Standard Peptide Custom Synthesis Service Sales Value Share by Type (2021-2026)
Table 21. Global Standard Peptide Custom Synthesis Service Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Commercial
Table 23. Significant Companies of Academic Research
Table 24. Global Standard Peptide Custom Synthesis Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Standard Peptide Custom Synthesis Service Sales Value by Application (2021-2026) & (US$ Million)
Table 26. Global Standard Peptide Custom Synthesis Service Sales Value by Application (2027-2032) & (US$ Million)
Table 27. Global Standard Peptide Custom Synthesis Service Sales Value Share by Application (2021-2026)
Table 28. Global Standard Peptide Custom Synthesis Service Sales Value Share by Application (2027-2032)
Table 29. Global Standard Peptide Custom Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Standard Peptide Custom Synthesis Service Sales Value by Region (2021-2026) & (US$ Million)
Table 31. Global Standard Peptide Custom Synthesis Service Sales Value Share by Region (2021-2026)
Table 32. Global Standard Peptide Custom Synthesis Service Sales Value by Region (2027-2032) & (US$ Million)
Table 33. Global Standard Peptide Custom Synthesis Service Sales Value Share by Region (2027-2032)
Table 34. Global Standard Peptide Custom Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global Standard Peptide Custom Synthesis Service Sales Value by Country (2021-2026) & (US$ Million)
Table 36. Global Standard Peptide Custom Synthesis Service Sales Value Market Share by Country (2021-2026)
Table 37. Global Standard Peptide Custom Synthesis Service Sales Value by Country (2027-2032) & (US$ Million)
Table 38. Global Standard Peptide Custom Synthesis Service Sales Value Market Share by Country (2027-2032)
Table 39. Bachem Company Information
Table 40. Bachem Business Overview
Table 41. Bachem Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 42. Bachem Standard Peptide Custom Synthesis Service Product Portfolio
Table 43. Bachem Recent Development
Table 44. PolyPeptide Company Information
Table 45. PolyPeptide Business Overview
Table 46. PolyPeptide Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. PolyPeptide Standard Peptide Custom Synthesis Service Product Portfolio
Table 48. PolyPeptide Recent Development
Table 49. GL Biochem Company Information
Table 50. GL Biochem Business Overview
Table 51. GL Biochem Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 52. GL Biochem Standard Peptide Custom Synthesis Service Product Portfolio
Table 53. GL Biochem Recent Development
Table 54. Xinbang Company Information
Table 55. Xinbang Business Overview
Table 56. Xinbang Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 57. Xinbang Standard Peptide Custom Synthesis Service Product Portfolio
Table 58. Xinbang Recent Development
Table 59. Hybio Company Information
Table 60. Hybio Business Overview
Table 61. Hybio Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Hybio Standard Peptide Custom Synthesis Service Product Portfolio
Table 63. Hybio Recent Development
Table 64. USVPeptides Company Information
Table 65. USVPeptides Business Overview
Table 66. USVPeptides Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. USVPeptides Standard Peptide Custom Synthesis Service Product Portfolio
Table 68. USVPeptides Recent Development
Table 69. Thermofischer Company Information
Table 70. Thermofischer Business Overview
Table 71. Thermofischer Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. Thermofischer Standard Peptide Custom Synthesis Service Product Portfolio
Table 73. Thermofischer Recent Development
Table 74. ScinoPharm Company Information
Table 75. ScinoPharm Business Overview
Table 76. ScinoPharm Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. ScinoPharm Standard Peptide Custom Synthesis Service Product Portfolio
Table 78. ScinoPharm Recent Development
Table 79. Genscript Company Information
Table 80. Genscript Business Overview
Table 81. Genscript Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. Genscript Standard Peptide Custom Synthesis Service Product Portfolio
Table 83. Genscript Recent Development
Table 84. AnaSpec Company Information
Table 85. AnaSpec Business Overview
Table 86. AnaSpec Standard Peptide Custom Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. AnaSpec Standard Peptide Custom Synthesis Service Product Portfolio
Table 88. AnaSpec Recent Development
Table 89. New England Peptide Company Information
Table 90. New England Peptide Business Overview
Table 91. New England Peptide Standard Peptide Custom Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 92. New England Peptide Standard Peptide Custom Synthesis Service Product Portfolio
Table 93. New England Peptide Recent Development
Table 94. CPC Scientific Company Information
Table 95. CPC Scientific Business Overview
Table 96. CPC Scientific Standard Peptide Custom Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 97. CPC Scientific Standard Peptide Custom Synthesis Service Product Portfolio
Table 98. CPC Scientific Recent Development
Table 99. JPT Company Information
Table 100. JPT Business Overview
Table 101. JPT Standard Peptide Custom Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 102. JPT Standard Peptide Custom Synthesis Service Product Portfolio
Table 103. JPT Recent Development
Table 104. 21st Century Bio Company Information
Table 105. 21st Century Bio Business Overview
Table 106. 21st Century Bio Standard Peptide Custom Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 107. 21st Century Bio Standard Peptide Custom Synthesis Service Product Portfolio
Table 108. 21st Century Bio Recent Development
Table 109. LifeTein Company Information
Table 110. LifeTein Business Overview
Table 111. LifeTein Standard Peptide Custom Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 112. LifeTein Standard Peptide Custom Synthesis Service Product Portfolio
Table 113. LifeTein Recent Development
Table 114. Proimmune Company Information
Table 115. Proimmune Business Overview
Table 116. Proimmune Standard Peptide Custom Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 117. Proimmune Standard Peptide Custom Synthesis Service Product Portfolio
Table 118. Proimmune Recent Development
Table 119. Biomatik Company Information
Table 120. Biomatik Business Overview
Table 121. Biomatik Standard Peptide Custom Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 122. Biomatik Standard Peptide Custom Synthesis Service Product Portfolio
Table 123. Biomatik Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Authors List of This Report
Table 126. Secondary Sources
Table 127. Primary Sources
List of Figures
Figure 1. Standard Peptide Custom Synthesis Service Product Image
Figure 2. Global Standard Peptide Custom Synthesis Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Standard Peptide Custom Synthesis Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Standard Peptide Custom Synthesis Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. CRO Peptides Image
Figure 8. CMO Peptides Image
Figure 9. Generic API Peptides Image
Figure 10. Global Standard Peptide Custom Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Standard Peptide Custom Synthesis Service Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Standard Peptide Custom Synthesis Service Sales Value Share by Type (2021-2032)
Figure 13. Commercial Image
Figure 14. Academic Research Image
Figure 15. Global Standard Peptide Custom Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 16. Global Standard Peptide Custom Synthesis Service Sales Value Share 2021 VS 2025 VS 2032
Figure 17. Global Standard Peptide Custom Synthesis Service Sales Value Share by Application (2021-2032)
Figure 18. Global Standard Peptide Custom Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 19. Global Standard Peptide Custom Synthesis Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 20. North America Standard Peptide Custom Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 21. North America Standard Peptide Custom Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 22. Europe Standard Peptide Custom Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 23. Europe Standard Peptide Custom Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Asia-Pacific Standard Peptide Custom Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 25. Asia-Pacific Standard Peptide Custom Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 26. South America Standard Peptide Custom Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 27. South America Standard Peptide Custom Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Middle East & Africa Standard Peptide Custom Synthesis Service Sales Value (2021-2032) & (US$ Million)
Figure 29. Middle East & Africa Standard Peptide Custom Synthesis Service Sales Value Share by Country (%), 2025 VS 2032
Figure 30. USA Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 31. USA Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 32. USA Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 33. Canada Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. Canada Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. Canada Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Mexico Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Mexico Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Mexico Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Germany Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Germany Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Germany Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. France Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. France Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. France Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. U.K. Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. U.K. Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. U.K. Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. Italy Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. Italy Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. Italy Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Spain Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Spain Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Spain Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Russia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Russia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Russia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Netherlands Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Netherlands Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Netherlands Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Nordic Countries Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Nordic Countries Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. China Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. China Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. China Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Japan Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Japan Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Japan Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. South Korea Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. South Korea Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. South Korea Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. India Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. India Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. India Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. Australia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. Australia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. Australia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Southeast Asia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Southeast Asia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Brazil Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Brazil Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Brazil Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Argentina Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Argentina Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Argentina Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Chile Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Chile Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Chile Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Colombia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Colombia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Colombia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Peru Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Peru Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Peru Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Saudi Arabia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Saudi Arabia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Israel Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Israel Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Israel Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. UAE Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. UAE Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. UAE Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Turkey Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Turkey Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Turkey Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Iran Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Iran Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Iran Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Egypt Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Egypt Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Egypt Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Years Considered
Figure 115. Research Process
Figure 116. Key Executives Interviewed
Scope & coverage.
Types
- CRO Peptides
- CMO Peptides
- Generic API Peptides
Applications
- Commercial
- Academic Research
Companies covered
- Bachem
- PolyPeptide
- GL Biochem
- Xinbang
- Hybio
- USVPeptides
- Thermofischer
- ScinoPharm
- Genscript
- AnaSpec
- New England Peptide
- CPC Scientific
- JPT
- 21st Century Bio
- LifeTein
- Proimmune
- Biomatik
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Standard Peptide Custom Synthesis Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Standard Peptide Custom Synthesis Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Standard Peptide Custom Synthesis Service Market Dynamics
- 2.1 Standard Peptide Custom Synthesis Service Industry Trends
- 2.2 Standard Peptide Custom Synthesis Service Industry Drivers
- 2.3 Standard Peptide Custom Synthesis Service Industry Opportunities and Challenges
- 2.4 Standard Peptide Custom Synthesis Service Industry Restraints
3 Standard Peptide Custom Synthesis Service Market by Company
- 3.1 Global Standard Peptide Custom Synthesis Service Company Revenue Ranking in 2025
- 3.2 Global Standard Peptide Custom Synthesis Service Revenue by Company (2021-2026)
- 3.3 Global Standard Peptide Custom Synthesis Service Company Ranking (2024-2026)
- 3.4 Global Standard Peptide Custom Synthesis Service Company Manufacturing Base and Headquarters
- 3.5 Global Standard Peptide Custom Synthesis Service Company Product Type and Application
- 3.6 Global Standard Peptide Custom Synthesis Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Standard Peptide Custom Synthesis Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Standard Peptide Custom Synthesis Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Standard Peptide Custom Synthesis Service Market by Type
- 4.1 Standard Peptide Custom Synthesis Service Type Introduction
- 4.1.1 CRO Peptides
- 4.1.2 CMO Peptides
- 4.1.3 Generic API Peptides
- 4.2 Global Standard Peptide Custom Synthesis Service Sales Value by Type
- 4.2.1 Global Standard Peptide Custom Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Standard Peptide Custom Synthesis Service Sales Value by Type (2021-2032)
- 4.2.3 Global Standard Peptide Custom Synthesis Service Sales Value Share by Type (2021-2032)
5 Standard Peptide Custom Synthesis Service Market by Application
- 5.1 Standard Peptide Custom Synthesis Service Application Introduction
- 5.1.1 Commercial
- 5.1.2 Academic Research
- 5.2 Global Standard Peptide Custom Synthesis Service Sales Value by Application
- 5.2.1 Global Standard Peptide Custom Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Standard Peptide Custom Synthesis Service Sales Value by Application (2021-2032)
- 5.2.3 Global Standard Peptide Custom Synthesis Service Sales Value Share by Application (2021-2032)
6 Standard Peptide Custom Synthesis Service Regional Value Analysis
- 6.1 Global Standard Peptide Custom Synthesis Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Standard Peptide Custom Synthesis Service Sales Value by Region (2021-2032)
- 6.2.1 Global Standard Peptide Custom Synthesis Service Sales Value by Region: 2021-2026
- 6.2.2 Global Standard Peptide Custom Synthesis Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Standard Peptide Custom Synthesis Service Sales Value (2021-2032)
- 6.3.2 North America Standard Peptide Custom Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Standard Peptide Custom Synthesis Service Sales Value (2021-2032)
- 6.4.2 Europe Standard Peptide Custom Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Standard Peptide Custom Synthesis Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Standard Peptide Custom Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Standard Peptide Custom Synthesis Service Sales Value (2021-2032)
- 6.6.2 South America Standard Peptide Custom Synthesis Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Standard Peptide Custom Synthesis Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Standard Peptide Custom Synthesis Service Sales Value Share by Country, 2025 VS 2032
7 Standard Peptide Custom Synthesis Service Country-level Value Analysis
- 7.1 Global Standard Peptide Custom Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Standard Peptide Custom Synthesis Service Sales Value by Country (2021-2032)
- 7.2.1 Global Standard Peptide Custom Synthesis Service Sales Value by Country (2021-2026)
- 7.2.2 Global Standard Peptide Custom Synthesis Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Standard Peptide Custom Synthesis Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Standard Peptide Custom Synthesis Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Standard Peptide Custom Synthesis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Bachem
- 8.1.1 Bachem Company Information
- 8.1.2 Bachem Business Overview
- 8.1.3 Bachem Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Bachem Standard Peptide Custom Synthesis Service Product Portfolio
- 8.1.5 Bachem Recent Developments
- 8.2 PolyPeptide
- 8.2.1 PolyPeptide Company Information
- 8.2.2 PolyPeptide Business Overview
- 8.2.3 PolyPeptide Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.2.4 PolyPeptide Standard Peptide Custom Synthesis Service Product Portfolio
- 8.2.5 PolyPeptide Recent Developments
- 8.3 GL Biochem
- 8.3.1 GL Biochem Company Information
- 8.3.2 GL Biochem Business Overview
- 8.3.3 GL Biochem Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.3.4 GL Biochem Standard Peptide Custom Synthesis Service Product Portfolio
- 8.3.5 GL Biochem Recent Developments
- 8.4 Xinbang
- 8.4.1 Xinbang Company Information
- 8.4.2 Xinbang Business Overview
- 8.4.3 Xinbang Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Xinbang Standard Peptide Custom Synthesis Service Product Portfolio
- 8.4.5 Xinbang Recent Developments
- 8.5 Hybio
- 8.5.1 Hybio Company Information
- 8.5.2 Hybio Business Overview
- 8.5.3 Hybio Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Hybio Standard Peptide Custom Synthesis Service Product Portfolio
- 8.5.5 Hybio Recent Developments
- 8.6 USVPeptides
- 8.6.1 USVPeptides Company Information
- 8.6.2 USVPeptides Business Overview
- 8.6.3 USVPeptides Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.6.4 USVPeptides Standard Peptide Custom Synthesis Service Product Portfolio
- 8.6.5 USVPeptides Recent Developments
- 8.7 Thermofischer
- 8.7.1 Thermofischer Company Information
- 8.7.2 Thermofischer Business Overview
- 8.7.3 Thermofischer Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Thermofischer Standard Peptide Custom Synthesis Service Product Portfolio
- 8.7.5 Thermofischer Recent Developments
- 8.8 ScinoPharm
- 8.8.1 ScinoPharm Company Information
- 8.8.2 ScinoPharm Business Overview
- 8.8.3 ScinoPharm Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.8.4 ScinoPharm Standard Peptide Custom Synthesis Service Product Portfolio
- 8.8.5 ScinoPharm Recent Developments
- 8.9 Genscript
- 8.9.1 Genscript Company Information
- 8.9.2 Genscript Business Overview
- 8.9.3 Genscript Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Genscript Standard Peptide Custom Synthesis Service Product Portfolio
- 8.9.5 Genscript Recent Developments
- 8.10 AnaSpec
- 8.10.1 AnaSpec Company Information
- 8.10.2 AnaSpec Business Overview
- 8.10.3 AnaSpec Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.10.4 AnaSpec Standard Peptide Custom Synthesis Service Product Portfolio
- 8.10.5 AnaSpec Recent Developments
- 8.11 New England Peptide
- 8.11.1 New England Peptide Company Information
- 8.11.2 New England Peptide Business Overview
- 8.11.3 New England Peptide Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.11.4 New England Peptide Standard Peptide Custom Synthesis Service Product Portfolio
- 8.11.5 New England Peptide Recent Developments
- 8.12 CPC Scientific
- 8.12.1 CPC Scientific Company Information
- 8.12.2 CPC Scientific Business Overview
- 8.12.3 CPC Scientific Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.12.4 CPC Scientific Standard Peptide Custom Synthesis Service Product Portfolio
- 8.12.5 CPC Scientific Recent Developments
- 8.13 JPT
- 8.13.1 JPT Company Information
- 8.13.2 JPT Business Overview
- 8.13.3 JPT Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.13.4 JPT Standard Peptide Custom Synthesis Service Product Portfolio
- 8.13.5 JPT Recent Developments
- 8.14 21st Century Bio
- 8.14.1 21st Century Bio Company Information
- 8.14.2 21st Century Bio Business Overview
- 8.14.3 21st Century Bio Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.14.4 21st Century Bio Standard Peptide Custom Synthesis Service Product Portfolio
- 8.14.5 21st Century Bio Recent Developments
- 8.15 LifeTein
- 8.15.1 LifeTein Company Information
- 8.15.2 LifeTein Business Overview
- 8.15.3 LifeTein Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.15.4 LifeTein Standard Peptide Custom Synthesis Service Product Portfolio
- 8.15.5 LifeTein Recent Developments
- 8.16 Proimmune
- 8.16.1 Proimmune Company Information
- 8.16.2 Proimmune Business Overview
- 8.16.3 Proimmune Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Proimmune Standard Peptide Custom Synthesis Service Product Portfolio
- 8.16.5 Proimmune Recent Developments
- 8.17 Biomatik
- 8.17.1 Biomatik Company Information
- 8.17.2 Biomatik Business Overview
- 8.17.3 Biomatik Standard Peptide Custom Synthesis Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Biomatik Standard Peptide Custom Synthesis Service Product Portfolio
- 8.17.5 Biomatik Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst